Grant Private Wealth Management’s AbbVie ABBV Stock Holding History

Grant Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	4,652 +530	+13%	+$114K	0.49%	38
2026 Q1	$897K	Buy	4,122 +907	+28%	+$201K	0.48%	47
2025 Q4	$735K	Buy	3,215 +300	+10%	+$68.3K	0.44%	46
2025 Q3	$675K	Sell	2,915 -8,979	-75%	-$1.83M	0.42%	51
2025 Q2	$2.21M	Buy	11,894 +9,514	+400%	+$1.77M	1.25%	27
2025 Q1	$499K	Buy	2,380 +686	+40%	+$133K	0.54%	53
2024 Q4	$301K	Buy	+1,694	New	+$311K	0.32%	85

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Grant Private Wealth Management's ABBV Position: Q2 2026 in Review

Grant Private Wealth Management increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $114K and bringing the position to 4,652 shares worth $1.17M. The position accounts for 0.49% of the portfolio, ranked #38.

Grant Private Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.21M in Q2 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Grant Private Wealth Management held 4,652 shares of AbbVie worth $1.17M as of Q2 2026.
Grant Private Wealth Management bought 530 AbbVie shares in Q2 2026, an estimated $114K.
AbbVie made up 0.49% of Grant Private Wealth Management's portfolio in Q2 2026, its #38 holding.
Grant Private Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Grant Private Wealth Management's AbbVie position peaked at $2.21M in Q2 2025.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Grant Private Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.